News & Insights
Explore research, partnerships, manufacturing breakthroughs and announcements shaping the future of protein therapeutics.
Constructive Bio, a leading synthetic biology company, today announces the appointment of Jim Weissman to its Board of Directors.
May 27, 2026
Constructive Bio and RxCelerate have partnered to combine programmable biology and ncAA-enabled protein engineering with drug design and development capabilities,…
November 19, 2025
Constructive Bio was selected by Nature Biotechnology as a 2025 Editor’s Pick, recognising the company’s synthetic genomics platform and use…
October 11, 2025
As featured in
- The Observer
- SynBioBeta
- Nature Biotechnology
- The Sunday Times
- UK Government DSIT
News, Updates &
Media Coverage
Company announcements, scientific updates, press releases, and external media coverage.
White Papers
In-depth technical briefs, platform insights, and thought leadership for partners and researchers.
June 11, 2026
Genome synthesis is the ability to write DNA at the scale of entire chromosomes and genomes. It is fundamentally different…
June 11, 2026
Genetic code expansion uses whole-genome recoding to free up codons and assign them to amino acids that biology has never…
June 11, 2026
Genome synthesis is the ability to write DNA at the scale of entire chromosomes and genomes. It is fundamentally different…
Scientific Publications
Published research underpinning the Constructive Bio platform — from fundamental genetic code expansion to scalable biomanufacturing.
May 22, 2026
Syn57 dramatically expands the ‘codon space’ available for non-canonical amino acid incorporation, from three freed codons in Syn61 to seven…
June 1, 2025
Viral contamination is a major cost and quality risk in biomanufacturing. Phage infection can wipe out an entire production run,…
December 1, 2024
Speed matters in drug development. Automating tRNA generation means Constructive Bio can rapidly create the molecular machinery needed to incorporate…
